Altamira Therapeutics Stock (NASDAQ: CYTO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.62K / 450.18K |
Day Range | - - - |
52 Wk Range | 0.73 - 17.20 |
Market Cap | $2.42M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 5.61% |
Days to Cover | 1.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Altamira Therapeutics (NASDAQ:CYTO) through any online brokerage.
Other companies in Altamira Therapeutics’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
There is no analysis for Altamira Therapeutics to provide a consensus price target.
The stock price for Altamira Therapeutics (NASDAQ: CYTO) is $0.7477 last updated September 19, 2024 at 8:14 AM EDT.
There are no upcoming dividends for Altamira Therapeutics.
Altamira Therapeutics’s H1 earnings are confirmed for Tuesday, October 1, 2024.
There is no upcoming split for Altamira Therapeutics.
Altamira Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.